New ALS drug stabilizes decline with improved strength, mobility for some – WashU Medicine

Rickey Malloy who receives tofersen treatment for SOD1-ALS at WashU Medicine, plays a round of golf with his wife, Jenny, and their son, Kash.

New ALS drug stabilizes decline with improved strength, mobility for some

Long-term use of tofersen slows ALS disease progression in people with a genetic subtype, provides hope for treating other forms of ALS